GlobeNewswire

San Diego-based Park Mental Health Treatment Facility Highlights Importance of Mental Wellness Recognized as Year-Round Healthcare Priority
17/09/2026
Mental Wellness Requires Preventive Approach, Too San Diego, CA., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Each year, specific months are dedicated to bringing awareness to various mental health topics; depression, PTSD, [...]
LQpay Introduces Custom AI Assistant LuQ, Bringing AI Directly into the Healthcare Payments Experience
17/09/2026
LuQ marks the first step in LQpay’s broader strategy to leverage AI and emerging technologies to simplify workflows, enhance automation and help healthcare organizations work more efficiently PLANTATION, Fla., Sept. 17 [...]
Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement
17/09/2026
Combined company to focus on developing first-in-class next-generation medicines for cardioendocrine diseases Marea has multiple late-stage clinical product candidates: MAR001/005 for severe hypertriglyceridemia (sHTG) [...]
TimelyCare Unveils "Connected Care for Every Student," with an AI Well-being Guide as an Easier First Step
17/09/2026
Built for every student, including those who would never book an appointment, the model pairs an AI well-being guide with human coaching and licensed clinical care. Fort Worth, TX, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
Fifteen Students Living With IBD Receive Scholarships to Help Pursue Their Education
17/09/2026
The AbbVie IBD Scholarship Program marks 15 years of recognizing the resilience and ambitions of students across Canada living with Crohn’s disease or ulcerative colitis TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Crohn [...]
Quinze étudiants atteints d’une MII reçoivent des bourses pour poursuivre leurs études
17/09/2026
Le programme de bourses d’études MII d’AbbVie souligne 15 ans de reconnaissance de la résilience et des ambitions des étudiants qui vivent avec la maladie de Crohn ou la colite ulcéreuse à travers le Canada TORONTO, 17 [...]
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
17/09/2026
SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today [...]
Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
17/09/2026
New Filing Seeks Broad Protection Around Creative Medical’s Cell-Free Regenerative Platform, Including Product Composition, Functional Potency, Manufacturing Controls and Additional Therapeutic Applications PHOENIX, [...]
Wandercraft Launches Eve™, the World’s First Self-Balancing Personal Exoskeleton, Bringing Hands-Free Upright Mobility to the Home
17/09/2026
FDA-cleared Eve is now commercially available in the U.S. to eligible adults with spinal cord injuries at any level, supported by a growing network for evaluation, training, reimbursement, delivery, and service NEW YORK [...]
Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction
17/09/2026
BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced it has [...]
Precision Optics Announces Initial Engineering Order from New Satellite Optical Communications Customer
17/09/2026
Initial order establishes second satellite laser communication customer and supports development roadmap targeting production in approximately 6-12 months LITTLETON, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Precision [...]
Devoted Health’s Medicare Advantage Plans Are Now Available on USAA’s Medicare Marketplace
17/09/2026
Devoted’s Medicare Advantage plans will be available to USAA members and customers as part of a growing portfolio of Medicare health insurance options from USAA WALTHAM, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Devoted [...]
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
17/09/2026
Chief Commercial Officer Bryan Downey Joins Panel Discussion on Reinventing the Launch Playbook for Small and Mid-Size Pharma KANSAS CITY, Kan., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a [...]
Recludix Pharma to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
17/09/2026
SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy [...]
First Insight Corporation Launches The Focal Point Podcast
17/09/2026
Monthly conversations on where AI is changing healthcare, where it falls short, and what responsible innovation looks like PORTLAND, Ore., Sept. 17, 2026 (GLOBE NEWSWIRE) -- First Insight Corporation launched The Focal [...]
Aerska Appoints Laura Sepp-Lorenzino to Scientific Advisory Board
17/09/2026
Appointment supports Aerska's progression of its antibody-oligo conjugate platform and growing pipeline of RNA therapeutics for CNS disease Laura brings decades of leadership in developing complex genetic medicines from [...]
Matisse Pharmaceuticals closed Series A financing round to advance isupartob sodium through phase 2 clinical development
17/09/2026
Geleen, September 17, 2026 Matisse Pharmaceuticals B.V., a clinical stage company developing isupartob sodium for the treatment of sepsis, today announced the successful completion of its Series A financing round. The € [...]
Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding
17/09/2026
Heavy menstrual bleeding is reported in approximately 1 in 3 reproductive-aged women, according to the American College of Obstetricians and Gynecologists, with approximately 23 million seeking care from a healthcare [...]
Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026
17/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum